Treatments
499 articles
Truly Grateful
Cedric Robins, Sr., is truly grateful to be a long-term survivor of pancreatic cancer. He knew something wasn’t right and he listened to his body.
Every Day is a Good Day
Ed Duncan is a long-term survivor of pancreatic cancer. As survivor he has a stronger appreciation for life, and a renewed bond with his wife Kathie.
Let’s Win Pancreatic Cancer Short PSA
Part of winning the battle against pancreatic cancer is to hope. Watch our public service announcement to learn more about Let’s Win.
Let’s Win! Pancreatic Cancer Long PSA
Part of winning the battle against pancreatic cancer is to hope. Join us to learn about upcoming science and read My Treatment stories from patients.
Meet the Researcher: Hiroyuki Kato, M.D., Ph.D.
Researcher Dr. Hiroyuki Kato has traveled from Japan to Boston for his research on IPMNs and pancreatic cancer.
Going After a Specialized Radiation Treatment
Don Myrah wanted more than chemotherapy. He read about a specialized radiation treatment and directly contacted the company behind it.
Have Hope
Andy Seynaeve has undergone many rounds of chemotherapy but he has had a great response. Best of all, he has hope.
When Certain Chemotherapy Drugs Are in Short Supply
It’s been all over the news–some chemotherapy drugs are in short supply. Dr. Allyson Ocean explains a doctor’s options in these situations.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
A Two-Part Journey, So Far
Three years after surgery to remove a pancreatic neuroendocrine tumor from the tail of his pancreas, Pablo Rodriguez was shocked to discover the cancer had returned.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.
CRISPR: A New Tool to Help Understand Cancer-Linked Mutations
Lukas Dow, Ph.D., is using CRISPR technology to find better ways to fight cancer by editing the genome.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!
New Vaccine Harnesses Power Of the Lymph Nodes
A promising new vaccine targets KRAS, the most common mutation in pancreatic cancer. Dr. Shubham Pant provides an update.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.